Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
why don't you post how insiders are dumping shares left & right instead of all your fancy "due diligence"
stocktwiter.com alert this morning, can't wait to short this
CMGR will be back to sub penny before the end of the month. Anyone willing to bet me?
CMGR prediction for tomorrow = 0.04
I wasn't wrong on DMGM nor INOL. Lets see tomorrow.
always do my DD, CMGR was one of the BIGGEST POS stocks prior to their R/S. They dumped billions of shares on shareholders to the point where they couldn't find any more people to buy them...so what do they do? A reverse split and sucker more idiots into their share selling gig
777stocks.com email on INOL received at 9:30
Dear High Rollers,
I did some research & found my NEW BIG PICK
The pick is: INOL - InoLife Technologies
INOL just release BIG NEWS pre market this morning & I believe this stock has a lot of potential to move higher.
The float is only 17,251,931 shares as of Jan 21, 2010.
The shares outstanding are only 73,419,448 shares as of Jan 21, 2010.
At a current price of 0.0027 this values INOC at LESS THEN $200,000!
To purchase a simple shell trading on the OTCBB to do a reverse merger with legal fees involved will cost you more then the $200,000 that INOL is currently valued at. This is a medical company that owns a proprietary metabolizing test that it is marketing to physicians and practitioners to identify how a patient's genetic makeup may affect the body's response to Plavix. Plavix is a $8-billion-a-year drug and considered to be the second best selling drug in the world, reduces the risk of heart attack, stroke, and cardiovascular death in patients with cardiovascular disease by making platelets less likely to form blood clots.
You can continue your research regarding INOL on their company website.
I believe INOL is an undiscovered GEM & I wouldn't want you to miss out on potentially JACKPOT SIZED PROFITS AHEAD!
Mr. 777
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
777STOCKS.COM NEVER HAS & NEVER WILL ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED AT 777STOCKS.COM &/OR ANY OF OUR SOCIAL NETWORKING PLATFORMS.
Full disclaimer can be read at: http://www.777stocks.com
PLEASE NOTE WELL: The 777Stocks.com employees are not Registered as an Investment Adviser in any jurisdiction whatsoever.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead 777Stocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. 777Stocks.com does not offer such advice or analysis, and 777Stocks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, 777Stocks.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, 777Stocks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. 777Stocks.com is not responsible for any claims made by the companies advertised herein.
777Stocks.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in 777Stocks.com statements and opinions and such statements and opinions cannot be considered independent. 777Stocks.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. Any and all compensation received in cash will always be disclosed below. 777Stocks.com never accepts compensation in free-trading shares for it's marketing services of the company being profiled, however the third party that might have compensated 777Stocks.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If 777Stocks.com ever accepts compensation in the form of free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services.
what goes up must come down. Look at DMGM
only DMGM is a scam, INOL looks like a legit company...but still this move needs a correction regardless
they gave 3,500% profit opp to whoever was on their list for sure. When I opened the email the ask was .0031
actually it was indeed a good trade, but really hard on bigger lots. If you are a 10-25k max share traded on a stock like this then yes. Anything over 25K at times was difficult to buy/sell
its ok, my point is a smart short never loses in the end. I proved this FACT right here earlier this week
only placed that called INOL at 9:30 was 777stocks.com
here is the email I received
Dear High Rollers,
I did some research & found my NEW BIG PICK
The pick is: INOL - InoLife Technologies
INOL just release BIG NEWS pre market this morning & I believe this stock has a lot of potential to move higher.
The float is only 17,251,931 shares as of Jan 21, 2010.
The shares outstanding are only 73,419,448 shares as of Jan 21, 2010.
At a current price of 0.0027 this values INOC at LESS THEN $200,000!
To purchase a simple shell trading on the OTCBB to do a reverse merger with legal fees involved will cost you more then the $200,000 that INOL is currently valued at. This is a medical company that owns a proprietary metabolizing test that it is marketing to physicians and practitioners to identify how a patient's genetic makeup may affect the body's response to Plavix. Plavix is a $8-billion-a-year drug and considered to be the second best selling drug in the world, reduces the risk of heart attack, stroke, and cardiovascular death in patients with cardiovascular disease by making platelets less likely to form blood clots.
You can continue your research regarding INOL on their company website.
I believe INOL is an undiscovered GEM & I wouldn't want you to miss out on potentially JACKPOT SIZED PROFITS AHEAD!
Mr. 777
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
777STOCKS.COM NEVER HAS & NEVER WILL ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED AT 777STOCKS.COM &/OR ANY OF OUR SOCIAL NETWORKING PLATFORMS.
Full disclaimer can be read at: http://www.777stocks.com
PLEASE NOTE WELL: The 777Stocks.com employees are not Registered as an Investment Adviser in any jurisdiction whatsoever.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead 777Stocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. 777Stocks.com does not offer such advice or analysis, and 777Stocks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, 777Stocks.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, 777Stocks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. 777Stocks.com is not responsible for any claims made by the companies advertised herein.
777Stocks.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in 777Stocks.com statements and opinions and such statements and opinions cannot be considered independent. 777Stocks.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. Any and all compensation received in cash will always be disclosed below. 777Stocks.com never accepts compensation in free-trading shares for it's marketing services of the company being profiled, however the third party that might have compensated 777Stocks.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If 777Stocks.com ever accepts compensation in the form of free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services.
I don't buy stocks, I wish I had bought this one when I got the alert though. I sign up on all the newsletters to find the stocks to short & I'm glad I didn't short this one...yet.
Should be a good short some time tomorrow.
Have to give credit where its due & out of the 50+ newsletter I signed up to only 1 emailed INOL when the market opened & that was 777stocks.com
hope you listened when I called this a scam
777stocks.com email on INOL received at 9:30
Dear High Rollers,
I did some research & found my NEW BIG PICK
The pick is: INOL - InoLife Technologies
INOL just release BIG NEWS pre market this morning & I believe this stock has a lot of potential to move higher.
The float is only 17,251,931 shares as of Jan 21, 2010.
The shares outstanding are only 73,419,448 shares as of Jan 21, 2010.
At a current price of 0.0027 this values INOC at LESS THEN $200,000!
To purchase a simple shell trading on the OTCBB to do a reverse merger with legal fees involved will cost you more then the $200,000 that INOL is currently valued at. This is a medical company that owns a proprietary metabolizing test that it is marketing to physicians and practitioners to identify how a patient's genetic makeup may affect the body's response to Plavix. Plavix is a $8-billion-a-year drug and considered to be the second best selling drug in the world, reduces the risk of heart attack, stroke, and cardiovascular death in patients with cardiovascular disease by making platelets less likely to form blood clots.
You can continue your research regarding INOL on their company website.
I believe INOL is an undiscovered GEM & I wouldn't want you to miss out on potentially JACKPOT SIZED PROFITS AHEAD!
Mr. 777
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
777STOCKS.COM NEVER HAS & NEVER WILL ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED AT 777STOCKS.COM &/OR ANY OF OUR SOCIAL NETWORKING PLATFORMS.
Full disclaimer can be read at: http://www.777stocks.com
PLEASE NOTE WELL: The 777Stocks.com employees are not Registered as an Investment Adviser in any jurisdiction whatsoever.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead 777Stocks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. 777Stocks.com does not offer such advice or analysis, and 777Stocks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, 777Stocks.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, 777Stocks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. 777Stocks.com is not responsible for any claims made by the companies advertised herein.
777Stocks.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in 777Stocks.com statements and opinions and such statements and opinions cannot be considered independent. 777Stocks.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. Any and all compensation received in cash will always be disclosed below. 777Stocks.com never accepts compensation in free-trading shares for it's marketing services of the company being profiled, however the third party that might have compensated 777Stocks.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If 777Stocks.com ever accepts compensation in the form of free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services.
One early buy in your past pumps have left many broke as well.
I know Rawnow, I suck, I'm sorry to have bothered you. You are far more superior then I am. Apology accepted?
Ok. "Rawnoc" I'm sorry! LOL
where are disclaimers for the HUNDREDS of paid promoters that post here? Isn't there an SEC law that states if compensated you must disclose?
SRCP looks good
with a o/s & a/s like that this stock will have no bid in due time
maybe
if everyone knew then I wouldn't be able to get any locates now would I?
mhmm my DD will be when the stock sees sub 0.05 tomorrow or later this week.
simple how many $2 or whatever SHARE EXCHANGE mergers have you seen actually work out the way the sheep thought they would? ZERO
SPPH is a STRONG SHORT 45M float & $90M MKT cap is HIGH & this stock will crash and burn faster then you can blink.
I will be shorting this tomorrow.
xbig do you know of a service that keeps track of dollar volume real time on pinks/otcbbs? That would help a ton trying to catch shorts intra day without having to scan the boards.
absolutely, eventually it actually works against you to hold your short too long if the stock is declining as then your net profit is less versus your net risk if the stock would turn around forcing you to cover.
my broker allows shorting no matter if I'm American, Canadian, Indian, or Pakistani. I can short ANY stock at ANY time & as much as I want.
why do you think I asked that question?
correct. But I'm short without having to oversell & I will sell short more Monday, but you are on to something about the 3 day rule but to get around that you can always cover & short again.
you asked if I have to cover because the month is over & I said nope. sad for longs...happy for me
130,000 to be exact at 0.15
let me log in and see
yes sir. 125,000 & will add more Monday at open.
tomorrow am the market is closed genius LOL
Now see the type of misinformed posters that are telling you to buy don't even know that the markets close on weekends
not missing the boat, actually liking the higher this goes to add more short, but just being reasonable letting newbies understand what they are buying before I take their $
LOI for $2 SHARE PURCHASE AGREEMENT...
First, it can be CANCELED at any time as it is a LOI.
Then even if it does go through I don't think you people realize you are getting stock in most likely an illiquid shell valued at $2 per share!
Think here.
$2 per SHARE PURCHASER AGREEMENT = SCAM
You will get stocks converted at a $2 per share price of a SHELL.
Use THRR as an example & the tank that happened when it all fell apart.